109 related articles for article (PubMed ID: 36597232)
21. Value of Texture Analysis of Intravoxel Incoherent Motion Parameters in Differential Diagnosis of Pancreatic Neuroendocrine Tumor and Pancreatic Adenocarcinoma.
Wang YW; Zhang XH; Wang BT; Wang Y; Liu MQ; Wang HY; Ye HY; Chen ZY
Chin Med Sci J; 2019 Mar; 34(1):1-9. PubMed ID: 30961774
[TBL] [Abstract][Full Text] [Related]
22. Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate-adjusted analysis at the pre-adjuvant chemotherapy timing.
Fu N; Qin K; Li J; Jin J; Jiang Y; Deng X; Shen B
Cancer Med; 2022 Sep; 11(18):3397-3406. PubMed ID: 35434972
[TBL] [Abstract][Full Text] [Related]
23. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
24. Does preoperative biliary drainage compromise the long-term survival of patients with pancreatic head carcinoma?
Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sasaki H; Hatano N; Kohmo T; Sueda T
J Surg Oncol; 2015 Mar; 111(3):270-6. PubMed ID: 25266938
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey.
Afsar CU; Gunaldi M; Kum P; Sahin B; Erkisi M; Kara IO; Paydas S; Duman BB; Ercolak V; Karaca F; Uyeturk U; Guner SI
Asian Pac J Cancer Prev; 2014; 15(21):9143-6. PubMed ID: 25422192
[TBL] [Abstract][Full Text] [Related]
26. iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma.
Wang WS; Liu XH; Liu LX; Lou WH; Jin DY; Yang PY; Wang XL
J Proteomics; 2013 Oct; 91():453-65. PubMed ID: 23851313
[TBL] [Abstract][Full Text] [Related]
27. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.
Lee KJ; Yi SW; Chung MJ; Park SW; Song SY; Chung JB; Park JY
Yonsei Med J; 2013 May; 54(3):643-9. PubMed ID: 23549809
[TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis by site of primary tumor of patients with unresectable locally-advanced or metastatic pancreatic adenocarcinoma receiving chemotherapy.
Colloca GA; Venturino A; Guarneri D
Clin Exp Metastasis; 2019 Dec; 36(6):519-525. PubMed ID: 31578654
[TBL] [Abstract][Full Text] [Related]
29. Associations of volumetric whole-body
Araç E; Can C; Kömek H
Hell J Nucl Med; 2020; 23(1):40-47. PubMed ID: 32361716
[TBL] [Abstract][Full Text] [Related]
30. [Factors influencing survival of patients with pancreatic adenocarcinoma after surgical resection].
Fang LP; Xu XY; Ji Y; Huang PW
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(8):606-611. PubMed ID: 29534390
[No Abstract] [Full Text] [Related]
31. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
Fernández A; Salgado M; García A; Buxò E; Vera R; Adeva J; Jiménez-Fonseca P; Quintero G; Llorca C; Cañabate M; López LJ; Muñoz A; Ramírez P; González P; López C; Reboredo M; Gallardo E; Sanchez-Cánovas M; Gallego J; Guillén C; Ruiz-Miravet N; Navarro-Pérez V; De la Cámara J; Alés-Díaz I; Pazo-Cid RA; Carmona-Bayonas A
BMC Cancer; 2018 Nov; 18(1):1185. PubMed ID: 30497432
[TBL] [Abstract][Full Text] [Related]
32. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
33. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K; Kowalski J; Kooby DA; El-Rayes BF; Staley CA; Adsay NV; Curran WJ; Landry JC; Maithel SK; Yu DS
Cancer; 2013 Sep; 119(17):3148-55. PubMed ID: 23720157
[TBL] [Abstract][Full Text] [Related]
34. The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.
Takeda T; Sasaki T; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Jpn J Clin Oncol; 2021 Apr; 51(5):728-736. PubMed ID: 33611490
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of chemotherapy after endoscopic double stenting for malignant duodenal and biliary obstructions in patients with advanced pancreatic cancer: a single-institution retrospective analysis.
Matsumoto K; Kato H; Horiguchi S; Tsutsumi K; Saragai Y; Takada S; Mizukawa S; Muro S; Uchida D; Tomoda T; Okada H
BMC Gastroenterol; 2018 Oct; 18(1):157. PubMed ID: 30367599
[TBL] [Abstract][Full Text] [Related]
37. [Concomitant arterial infusion chemotherapy with tamoxifen therapy for hepatic metastases from pancreatic adenocarcinoma--a preliminary report].
Saito H; Takamura A; Sakurai Y; Horio K; Ohta T; Yamano M; Sawaguchi Y; Sato Y
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2177-82. PubMed ID: 8239683
[TBL] [Abstract][Full Text] [Related]
38. [Correlation analysis of clinical indicators and liver failure-related prognostic score associated with prognosis in patients with amanita phalloides poisoning].
Liang X; Liu S; Wang B; Zhao X; Duan C; Hu X; Xie J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1178-1182. PubMed ID: 36567562
[TBL] [Abstract][Full Text] [Related]
39. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
Khan M; Ashraf MI; Syed AA; Hanif F
J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
[TBL] [Abstract][Full Text] [Related]
40. Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer.
Nishiofuku H; Tanaka T; Marugami N; Sho M; Akahori T; Nakajima Y; Kichikawa K
Eur Radiol; 2016 Jun; 26(6):1835-42. PubMed ID: 26385808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
